SciSparc Ltd. (NASDAQ:SPRC) Sees Significant Growth in Short Interest

SciSparc Ltd. (NASDAQ:SPRCGet Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 523,900 shares, an increase of 207.1% from the March 31st total of 170,600 shares. Based on an average daily volume of 1,290,000 shares, the days-to-cover ratio is presently 0.4 days. Currently, 21.4% of the company’s stock are short sold.

SciSparc Stock Performance

Shares of SciSparc stock traded up $0.06 during midday trading on Friday, hitting $1.32. The company had a trading volume of 192,438 shares, compared to its average volume of 868,613. SciSparc has a 52-week low of $1.15 and a 52-week high of $23.66. The company has a 50 day moving average of $2.42 and a 200 day moving average of $4.18.

SciSparc Company Profile

(Get Free Report)

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.

Further Reading

Receive News & Ratings for SciSparc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciSparc and related companies with MarketBeat.com's FREE daily email newsletter.